(Q43900263)

English

Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation (English)

1 reference

Europe PubMed Central

27 November 2017

cell differentiation

1 reference

based on heuristic

inferred from title

Theodorus H Van der Kwast

object named as

Theodorus H van der Kwast

6

0 references

0 references

author name string

Johan Jongsma

1

1 reference

Europe PubMed Central

27 November 2017

Monique H Oomen

2

1 reference

Europe PubMed Central

27 November 2017

Marinus A Noordzij

3

1 reference

Europe PubMed Central

27 November 2017

Wytske M Van Weerden

4

1 reference

Europe PubMed Central

27 November 2017

Gerard J M Martens

5

1 reference

Europe PubMed Central

27 November 2017

Fritz H Schröder

7

1 reference

Europe PubMed Central

27 November 2017

Gert J van Steenbrugge

8

1 reference

Europe PubMed Central

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2002

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

50

1 reference

Europe PubMed Central

27 November 2017

4

1 reference

Europe PubMed Central

27 November 2017

203-215

1 reference

Europe PubMed Central

27 November 2017

Neuroendocrine differentiation in human prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Expression, structure, and function of androgen receptor in advanced prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Proglucagon processing in islet and intestinal cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Structural organization of the gene encoding the neuroendocrine chaperone 7B2

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Human peptidylglycine alpha-amidating monooxygenase transcripts derived by alternative mRNA splicing of an unreported exon

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Secretogranin III is a sulfated protein undergoing proteolytic processing in the regulated secretory pathway.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Steroid-independent activation of androgen receptor in androgen-independent prostate cancer: a possible role for the MAP kinase signal transduction pathway?

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10049

21 January 2018

Identifiers

10.1002/PROS.10049

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43900263&oldid=2104253328"